|
JDP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62492241884138E-12 |
| Normal-vs-Stage2 |
1.00620000109686E-08 |
| Normal-vs-Stage3 |
9.48349998530773E-09 |
| Normal-vs-Stage4 |
3.07009999644947E-08 |
| Stage1-vs-Stage2 |
7.109600E-01 |
| Stage1-vs-Stage3 |
6.243000E-01 |
| Stage1-vs-Stage4 |
5.036200E-01 |
| Stage2-vs-Stage3 |
9.570600E-01 |
| Stage2-vs-Stage4 |
3.643600E-01 |
| Stage3-vs-Stage4 |
3.880800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
9.42568245676512E-12 |
| Normal-vs-Asian |
7.415700E-04 |
| Caucasian-vs-AfricanAmerican |
2.759800E-01 |
| Caucasian-vs-Asian |
4.897600E-01 |
| AfricanAmerican-vs-Asian |
7.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.90836235702818E-12 |
| Male-vs-Female |
6.057800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.89159998775779E-09 |
| Normal-vs-Extreme_Weight |
2.39663844325833E-12 |
| Normal-vs-Obese |
2.79443135298152E-13 |
| Normal-vs-Extreme_Obese |
1.10129999564279E-08 |
| Normal_Weight-vs-Extreme_Weight |
8.223000E-01 |
| Normal_Weight-vs-Obese |
8.456400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.003200E-01 |
| Extreme_Weight-vs-Obese |
9.713400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.014000E-01 |
| Obese-vs-Extreme_Obese |
3.451400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68989999771441E-08 |
| Normal-vs-Age(41-60Yrs) |
6.66133814775094E-16 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
1.72579999999645E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.706200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.542600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.185400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.213000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.666800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.281400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.83080003882219E-10 |
| Normal-VS-KIRP CIMP |
1.28249999509222E-08 |
| Normal-VS-Unclassified PRCC |
3.9862000034141E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.371200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.376000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.500800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.598300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.352600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.015440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
9.79390000210856E-08 |
| Normal-vs-N2 |
8.573000E-04 |
| N0-vs-N1 |
3.121800E-01 |
| N0-vs-N2 |
5.249800E-01 |
| N1-vs-N2 |
9.494200E-01 |
|
|
